Original Source(s)
Related Content
IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial
At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.
by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS
May 1, 2026
-
4 min
Celebrating Ophthalmic Innovation
Ophthalmology Management Chief Medical Editor Lisa Feulner, MD, PhD, introduces the publication’s 30th anniversary celebration of innovation.
May 1, 2026
-
3 min
From Babylon to Berlin
Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine
May 26, 2026
-
7 min